Organization
Malaria Consortium
7 clinical trials
Clinical trial
A Hybrid Effectiveness-implementation Study to Assess the Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Five Districts in Karamoja Region, UgandaStatus: Active (not recruiting), Estimated PCD: 2022-11-01
Clinical trial
Seasonal Malaria Chemoprevention Rapid Assessment Study MozambiqueStatus: Not yet recruiting, Estimated PCD: 2024-05-26
Clinical trial
Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in Northern Bahr Eel Ghazal, South Sudan: A Type 2 Hybrid Effectiveness-implementation Study Using a Convergent Mixed-methods ApproachStatus: Active (not recruiting), Estimated PCD: 2024-12-15
Clinical trial
Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Evaluated Using a Type Two Hybrid Implementation Science Observational StudyStatus: Active (not recruiting), Estimated PCD: 2022-06-21
Clinical trial
Seasonal Malaria Chemoprevention in Burkina Faso : Chemoprevention Efficacy StudyStatus: Active (not recruiting), Estimated PCD: 2022-10-01
Clinical trial
Clinical Trial to Evaluate Efficacy and Safety of Sulfadoxine/Pyrimethamine-Amodiaquine and Dihydroartemsinin-Piperaquine Plus Ivermectin Administered Monthly as Intermittent Preventive Treatment in School-aged Children in Burkina FasoStatus: Recruiting, Estimated PCD: 2024-05-31
Clinical trial
A Study Protocol to Assess the Chemoprevention Efficacy of Sulphadoxine-Pyrimethamine Plus Amodiaquine (SPAQ) and Resistance Marker Prevalence in Children 3-59 Months in Sokoto and Kwara States, Nigeria.Status: Recruiting, Estimated PCD: 2023-09-15